A Multi-center, Open, Long-term Follow-up Study to Evaluate the Efficacy and Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid arthritis: 5-year Results From the K0202 Extension Study
Age
19–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Subject who enrolled K0202 Clinical Trial(parent study) and has been given more than one medication.
2. Subjects who understand and voluntarily sign an informed consent form
You may not be if
1\. Any other condition which the investigator judges would make patient unsuitable for study participation
